Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients

Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, Qiongshu Wang, Qianchuan Huang, Yinjuan Ding, Wenxu Ni, Wanlei Wu, Shi Tang, Li Tan, Zhenhong Hu, Weitian Xu, Yong Zhang, Bo Zhang, Zhongzhi Tang, Xinhua Zhang, Honghua Li, Zhiguo Rao, Hui Jiang, Xingfeng Ren, Shengdian Wang, Shangen Zheng
doi: https://doi.org/10.1101/2020.03.06.20031856
Lei Liu
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanbing Liu
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaqiong Zheng
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiaojing Jiang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guomei Kou
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinya Ding
3Department of Clinical Laboratory, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qiongshu Wang
4Department of Disease Control and Prevention, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Qianchuan Huang
3Department of Clinical Laboratory, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yinjuan Ding
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wenxu Ni
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wanlei Wu
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shi Tang
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Li Tan
4Department of Disease Control and Prevention, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhenhong Hu
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Weitian Xu
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yong Zhang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Zhang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhongzhi Tang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xinhua Zhang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Honghua Li
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Zhiguo Rao
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hui Jiang
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xingfeng Ren
2Department of Infectious Diseases, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shengdian Wang
5CAS Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing 100101, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sxkzsg@sina.com sdwang@ibp.ac.cn
Shangen Zheng
1Department of Transfusion, General Hospital of Central Theater Command of PLA, Wuhan 430070, Hubei, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: sxkzsg@sina.com sdwang@ibp.ac.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background The outbreak of the recently emerged novel corona virus disease 2019 (COVID-19) poses a challenge for public health laboratories. We aimed to evaluate the diagnostic value of serological assay for SARS-CoV-2.

Methods A newly-developed ELISA assay for IgM and IgG antibodies against N protein of SARS-CoV-2 were used to screen the serums of 238 admitted hospital patients with confirmed or suspected SARS-CoV-2 infection from February 6 to February 14, 2020. SARS-CoV-2 RNA was detected by real time RT-PCR on pharyngeal swab specimens.

Findings Of the 238 patients, 194 (81.5%) were detected to be antibody (IgM and/or IgG) positive, which was significantly higher than the positive rate of viral RNA (64.3%). There was no difference in the positive rate of antibody between the confirmed patients (83.0%, 127/153) and the suspected patients (78.8%, 67/85) whose nucleic acid tests were negative. After the patients were defined to the different stages of disease based on the day when the test samples were collected, the analysis results showed that the antibody positive rates were very low in the first five days after initial onset of symptoms, and then rapidly increased as the disease progressed. After 10 days, the antibody positive rates jumped to above 80% from less than 50%. On the contrary, the positive rates of viral RNA kept above 60% in the first 11 days after initial onset of symptoms, and then rapidly decreased. In addition, half of the suspected patients with symptoms for 6-10 days were detected to be antibody positive.

Interpretation The suspected patients were most likely infected by SARS-CoV-2. Before the 11th day after initial onset of symptoms, nucleic acid test is important for confirmation of viral infection. The combination of serological assay can greatly improve the diagnostic efficacy. After that, the diagnosis for viral infection should be majorly dependent on serological assay.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was supported by the National Natural Science Foundation of China (81801984, 81830003); the National Key Research and Development Program of China (2019YFC130030); and the China Postdoctoral Science Foundation (2019M664008).

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The data used to support the findings of this study are included within the article.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted March 08, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients
Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, Qiongshu Wang, Qianchuan Huang, Yinjuan Ding, Wenxu Ni, Wanlei Wu, Shi Tang, Li Tan, Zhenhong Hu, Weitian Xu, Yong Zhang, Bo Zhang, Zhongzhi Tang, Xinhua Zhang, Honghua Li, Zhiguo Rao, Hui Jiang, Xingfeng Ren, Shengdian Wang, Shangen Zheng
medRxiv 2020.03.06.20031856; doi: https://doi.org/10.1101/2020.03.06.20031856
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A preliminary study on serological assay for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in 238 admitted hospital patients
Lei Liu, Wanbing Liu, Yaqiong Zheng, Xiaojing Jiang, Guomei Kou, Jinya Ding, Qiongshu Wang, Qianchuan Huang, Yinjuan Ding, Wenxu Ni, Wanlei Wu, Shi Tang, Li Tan, Zhenhong Hu, Weitian Xu, Yong Zhang, Bo Zhang, Zhongzhi Tang, Xinhua Zhang, Honghua Li, Zhiguo Rao, Hui Jiang, Xingfeng Ren, Shengdian Wang, Shangen Zheng
medRxiv 2020.03.06.20031856; doi: https://doi.org/10.1101/2020.03.06.20031856

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (163)
  • Allergy and Immunology (416)
  • Anesthesia (92)
  • Cardiovascular Medicine (865)
  • Dentistry and Oral Medicine (159)
  • Dermatology (98)
  • Emergency Medicine (251)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (397)
  • Epidemiology (8587)
  • Forensic Medicine (4)
  • Gastroenterology (390)
  • Genetic and Genomic Medicine (1765)
  • Geriatric Medicine (168)
  • Health Economics (373)
  • Health Informatics (1250)
  • Health Policy (624)
  • Health Systems and Quality Improvement (470)
  • Hematology (197)
  • HIV/AIDS (379)
  • Infectious Diseases (except HIV/AIDS) (10333)
  • Intensive Care and Critical Care Medicine (553)
  • Medical Education (192)
  • Medical Ethics (51)
  • Nephrology (214)
  • Neurology (1691)
  • Nursing (97)
  • Nutrition (252)
  • Obstetrics and Gynecology (328)
  • Occupational and Environmental Health (451)
  • Oncology (930)
  • Ophthalmology (264)
  • Orthopedics (102)
  • Otolaryngology (172)
  • Pain Medicine (114)
  • Palliative Medicine (40)
  • Pathology (254)
  • Pediatrics (538)
  • Pharmacology and Therapeutics (255)
  • Primary Care Research (209)
  • Psychiatry and Clinical Psychology (1782)
  • Public and Global Health (3863)
  • Radiology and Imaging (626)
  • Rehabilitation Medicine and Physical Therapy (322)
  • Respiratory Medicine (522)
  • Rheumatology (208)
  • Sexual and Reproductive Health (170)
  • Sports Medicine (158)
  • Surgery (191)
  • Toxicology (36)
  • Transplantation (101)
  • Urology (76)